SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Shorting stocks: Broken stocks - Analysis
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dr. Seuss who wrote (1443)7/22/1998 8:52:00 AM
From: Q.  Read Replies (1) of 2506
 
all: EQMDE is still restating results. Clearly this was the luckier of the two delistings for late 10k filings for FY 12/31/97, the other being PAMCE.

STATE COLLEGE, Pa. -(Dow Jones)- EquiMed Inc., a provider of oncology
and anesthesiology services, late Tuesday said it will restate results
for the first three quarters of 1997.
EquiMed (EQMDE) said its previously reported results for 1997 "should
no longer be relied upon."
EquiMed's shares were delisted by Nasdaq on June 22 because the
company was unable to complete its Form 10-K filing for fiscal 1997 with
the Securities and Exchange Commission. At the time, the company said it
expected to finalize the statements within 30 days.
The company also reported last month that its chief financial officer
resigned effective June 30. A successor has yet to be named.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News